Fig. 3
From: Tri©DB: an integrated platform of knowledgebase and reporting system for cancer precision medicine
An example of the detailed report for the gene EGFR, therapeutic drug osimertinib, and disease NSCLC in the second layer of data in Tri©DB. A Details of EGFR, including basic genomic annotation, population mutation profile, functional interpretation, therapy interpretation, pathway and interaction. B Details of the drug osimertinib, including approval information, indication, mechanism of action, clinical trial, and the three-dimensional structure. C Details of NSCLC, including disease classification, mutation carrier rate in the Western and Chinese population. D Germline mutation carrier rate was also provided in the disease report